Orbital Therapeutics
Cambridge
About Orbital Therapeutics
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, and automation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $270.0M
- Funding stage: M&A
- Last round: Series A (Apr 2023)
- Website: orbitaltx.com
- Phone: [email protected]
Industries & Categories
Alternative Medicine, Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orbital-therapeutics-51044 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.